CD79A and tuberculosis: Thus, a better understanding of the mechanisms underlying the development, induction, and function of IgA vs. IgG responses in humans as well as the identification of protective MTB target epitopes can form the basis for the rational design of a vaccine, which not only prevents TB disease, but also stable MTB infection.